Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Abatacept
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abatacept 125mg/1ml inj pre-filled disposable devices
1001030V0AAACAC
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | 2 |
|
Abatacept 125mg/1ml inj pre-filled syringes
1001030V0AAABAB
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abatacept 250mg powder for solution for infusion vials
1001030V0AAAAAA
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abatacept 50mg/0.4ml inj pre-filled syringes
1001030V0AAAEAE
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abatacept 87.5mg/0.7ml inj pre-filled syringes
1001030V0AAADAD
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Orencia 125mg/1ml solution for injection pre-filled syringes
1001030V0BBABAB
|
Orencia | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Orencia 250mg pdr for concentrate for inf vials
1001030V0BBAAAA
|
Orencia | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Orencia 50mg/0.4ml inj pre-filled syringes
1001030V0BBAEAE
|
Orencia | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Orencia 87.5mg/0.7ml inj pre-filled syringes
1001030V0BBADAD
|
Orencia | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Orencia ClickJect 125mg/1ml inj pre-filled pens
1001030V0BBACAC
|
Orencia | Abatacept | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.